Skip to main content

Volume 18 Supplement 1

The Novartis Ophthalmology Case Awards 2017

Research

This supplement and the meeting on which it was based were sponsored by Novartis (tracking number OPT17-C041). The articles have undergone the journal's standard peer review process for supplements. Novartis did not contribute to the content and all authors retained final control of the content and editorial decisions. Novartis have checked that the content was compliant with the Association of the British Pharmaceutical Industry Code of Practice. GT is the Editor for BMC Ophthalmology.

Edited by Guangde Tu.

In this supplement we are pleased to present clinical cases selected as finalists in the Novartis Ophthalmology Case Awards 2017.

The awards were open to all ophthalmologists in training, the case reports submitted for the Awards were judged by an independent panel of distinguished consultant ophthalmologists who selected those best case reports according to:

• Scientific interest

• Use of clinical acumen

• Clear and concise presentation

The quality of submissions was high, and the panel shortlisted cases in both the Retina and Glaucoma sections to present in person at finals days.

At the finals days, the judging panels selected the cases presented by David Dunleavy and Alastair Porteous (Glaucoma) and David Curragh (Retina) as the best in their respective section. Finalist and best case selection was wholly independent of Novartis.

The awards aim to help the development of presentation skills amongst ophthalmic trainees and to foster an environment for the sharing and transfer of experience and knowledge. This occurs through the discussion of challenging and interesting scenarios that arise in practice. The awards also drive an appreciation of the high quality of teaching that can be obtained from challenging cases which have been comprehensively worked-up and systematically managed by the trainees and their supervising consultants. 

Prof Yit Yang

Chairman of Retina Judging Panel

Visiting Professor University of Aston, Birmingham

Consultant Ophthalmologist

Royal Wolverhampton Hospitals NHS Trust

 

Mr Bruce James,

Chairman of Glaucoma Judging Panel

Consultant Ophthalmologist,

Stoke Mandeville Hospital, Bucks

  1. Dense Deposit Disease is a rare condition affecting the Bruch’s membrane and the glomerular basement membrane. We report the progression of the ocular manifestations over a 30 year follow up period, longer tha...

    Authors: Alan Cunningham and Ajay Kotagiri
    Citation: BMC Ophthalmology 2018 18(Suppl 1):228
  2. Diffuse unilateral subacute neuroretinitis (DUSN) is a rare cause of posterior uveitis in the United Kingdom. It typically presents unilaterally in children and young adults but rarely bilateral cases have bee...

    Authors: David S Curragh, Anne Ramsey, Sharon Christie and Eibhlin McLoone
    Citation: BMC Ophthalmology 2018 18(Suppl 1):218
  3. The surgical management of patients with uncontrolled glaucoma and scleroderma is challenging, as the hostile ocular surface poses a challenge to surgery. A serious complication is tube erosion, with the risk ...

    Authors: Gurjeet Jutley, Elizabeth Yang and Phillip Bloom
    Citation: BMC Ophthalmology 2018 18(Suppl 1):222
  4. Suprachoroidal haemorrhage is a rare complication of either medical anticoagulation treatment or intraocular surgical procedures. Suprachoroidal haemorrhages often have devastating visual outcome despite conse...

    Authors: Ibrahim Masri, Jonathan M. Smith, Nicholas K. Wride and Saurabh Ghosh
    Citation: BMC Ophthalmology 2018 18(Suppl 1):224
  5. This case highlights the important sequelae that can occur following the inadvertent implantation of a single-piece intraocular lens into the ciliary sulcus during cataract surgery; secondary pigment dispersio...

    Authors: Alastair Porteous and Laura Crawley
    Citation: BMC Ophthalmology 2018 18(Suppl 1):219
  6. Retinal vascular occlusions are uncommon in young people and require more in-depth investigation into the cause. Studies have revealed that a high level of circulating homocysteine poses a risk for retinal vas...

    Authors: Clare Shute
    Citation: BMC Ophthalmology 2018 18(Suppl 1):220
  7. Primary vitreoretinal lymphoma (PVRL) is a rare ocular condition and its diagnosis remains a challenge. The clinical presentation is variable and it can masquerade as chronic intermediate or posterior uveitis....

    Authors: Shi Zhuan Tan, Laura R. Steeples, Ramandeep Chhabra and Nicholas P. Jones
    Citation: BMC Ophthalmology 2018 18(Suppl 1):223
  8. The use of molecularly targeted therapy is becoming widespread in oncology. These agents cause tumour-specific genetic alterations in signal transduction pathways, hence less generalised toxicity. Dabrafenib, ...

    Authors: Pallavi Tyagi and Cynthia Santiago
    Citation: BMC Ophthalmology 2018 18(Suppl 1):221

Affiliated with

Annual Journal Metrics

  • 2022 Citation Impact
    2.0 - 2-year Impact Factor
    2.3 - 5-year Impact Factor
    1.152 - SNIP (Source Normalized Impact per Paper)
    0.715 - SJR (SCImago Journal Rank)

    2022 Speed
    24 days submission to first editorial decision for all manuscripts (Median)
    162 days submission to accept (Median)

    2022 Usage 
    1,808,882 downloads
    1,591 Altmetric mentions 

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here